MedPath

End Of Life in the Critically Ill patiEnt

Completed
Conditions
Terminal Illness
Intensive Care Unit Syndrome
Registration Number
NCT03392857
Lead Sponsor
French Society for Intensive Care
Brief Summary

The purpose of this multicentric study is to evaluate the perception of the quality of the end of life in intensive care units seen from the side of the caregivers, trough the CAESAR scale.

Detailed Description

More than 20% of deaths occur in hospital after a stay in intensive care units; up to half of them happens as result of a treatment limitation. Ensuring end-of-life quality is important, not only because is a moral duty of all caregivers, but also to prevent negative effects in close relatives of dead patients.

In an assessment of quality of in-hospital deaths involving 3793 patients, only 35% of the deaths were judged to be of acceptable quality by the nurses.

Assessment tools have been developed recently on this topic. Most studies have focused on the perception of end-of-life quality by close relatives, particularly through the CAESAR scale in the most recent one.

The main purpose of this multicentric study is to evaluate the perception of the quality of the end-of-life in intensive care units seen from the side of the caregivers, in relation to the new French legislative framework.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
514
Inclusion Criteria
  • Caregivers of intensive care unit whose patient has recently deceased
Exclusion Criteria
  • Refusal of participation by caregivers
  • Refusal of participation by family of deceased patient
  • Patient in cardiac arrest at the time of ICU admission.
  • Age of deceased patient was under 18 years
  • Patient in brain death

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
15 items questionnaire CAESARDepending of end-of-life duration, usually 6 hours.

The CAESAR scale assesses perceptions of palliative stage of patient's pathology, of patient's comfort, of presence and care of close relatives, with a score for each item ranging from 1 (traumatic experience) to 5 (soothing). The purpose of our study is to assess the perception of end-of-life quality seen from the caregivers' side, using the CAESAR scale.

Secondary Outcome Measures
NameTimeMethod
Analogic visual scale (0 to 10)Depending of end-of-life duration, usually 6 hours.

Analogic visual scale on end-of-life quality seen from the caregiver's side

Variables associated with the perception by caregivers of end-of-life qualitytime needed for the enrollment of caregivers of 5 to 15 consecutive deceased patients per center (depending on the size of the center): usually 1 month

Evaluate the variables associated with the perception by caregivers of end-of-life quality: proportion of treatment limitations, frequencies of conflicts between close relatives of dead patients and caregivers, frequencies end-of-life deep sedations, detailed description of current sedation practices, proportion of treatments, monitoring and blood tests maintained after treatment limitation during end-of-life .

Trial Locations

Locations (111)

Hôpital Saint-Esprit

🇫🇷

Agen, France

Centre Hospitalier Alès en Cévennes

🇫🇷

Alès, France

CHU Amiens

🇫🇷

Amiens, France

CHU d'Angers

🇫🇷

Angers, France

Hopital Privé d'Antony

🇫🇷

Antony, France

CH d'Argenteuil

🇫🇷

Argenteuil, France

Hopital Mercy

🇫🇷

Ars-Laquenexy, France

Centre Hospitalier René Dauffaut

🇫🇷

Avignon, France

Hopital Nord Franche Comté

🇫🇷

Belfort, France

CHU Besancon

🇫🇷

Besançon, France

Scroll for more (101 remaining)
Hôpital Saint-Esprit
🇫🇷Agen, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.